E7389 in Treating Patients With Recurrent or Progressive Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well E7389 works in treating patients with recurrent or
progressive stage IIIB or stage IV non-small cell lung cancer. Drugs used in chemotherapy,
such as E7389, work in different ways to stop the growth of tumor cells, either by killing
the cells or by stopping them from dividing.